MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2016 International Congress

June 19-23, 2016. Berlin, Germany.

View by Title View Sessions
View by Date

Monday, June 20, 2016

12:30pm-2:00pm
Modulation and mechanism for the neuroprotective effects of 17-beta-estradiol: Relevance to depressive symptoms in Parkinson’s disease

P. Kumar, N. Baquer (New Delhi, India)

Parkinson's disease: Non-motor symptoms  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Moist smokeless tobacco (Snus) use and risk of Parkinson’s disease: Meta-analysis of individual participant data from seven prospective observational studies

F. Yang, N.L. Pedersen, W. Ye, Z. Liu, M. Norberg, L. Forsgren, Y. Trolle Lagerros, R. Bellocco, L. Alfredsson, A. Knutsson, J.H. Jansson, R. Galanti, A.C.J. Lager, M. Araghi, M. Lundberg, C. Magnusson, K. Wirdefeldt (Stockholm, Sweden)

Epidemiology and Quality of Life
12:30pm-2:00pm
Morbidity and comorbidity of deep brain stimulation for Parkinson’s disease – A thirteen-years retrospective cohort study

S.Y. Chen, Y.H. Pan, S.H. Lin (Hualien, Taiwan)

Surgical therapy: Parkinson's disease  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Mortality after deep brain stimulation surgery for patients with advanced Parkinson’s disease

H.S. Ryu, S. You, M.J. Kim, Y.J. Kim, J. Kim, K. Kim, S.J. Chung (Seoul, Korea)

Surgical therapy: Parkinson's disease  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Motivators and barriers to participation in exercise in Parkinson’s disease

M. Afshari, Y. Kianirad, D. Bega (Chicago, IL, USA)

Quality of life/caregiver burden in movement disorders  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Motor and non-motor symptoms in Parkinson’s disease: Correlation and impact on quality of life and activities of daily living

P. Bugalho, T. Lampreia, R. Miguel, M. Mendonça, A. Caetano, R. Barbosa (Lisbon, Portugal)

Parkinson's disease: Non-motor symptoms  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Motor features and response to levodopa in Parkinson’s disease with normal olfactory function

M. Rossi, A. Medina Escobar, A. Bril, P. Millar Vernetti, J.I. De Palo, D. Cerquetti, M. Merello (Buenos Aires, Argentina)

Parkinson's disease: Non-motor symptoms  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Motor rigidity selectively associates with impaired odor identification in Parkinson’s disease

J.D. Haugen, M.L.T.M. Muller, V. Kotagal, K.A. Frey, R.L. Albin, N.I. Bohnen (Ann Arbor, MI, USA)

Parkinson's disease: Non-motor symptoms  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Motor symptoms in patients with early stages of Parkinson’s disease

E.N. Gubanova, N.V. Fedorova (Moscow, Russia)

Quality of life/caregiver burden in movement disorders  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Movement disorders (Parkinson’s disease) in Uzbekistan: Epidemiologic, clinical and therapeutic aspects

N. Eshakulova, A. Umarov, N. Tuychibaeva, G. Rakhimbaeva, M. Ataniyazov (Tashkent, Uzbekistan)

Epidemiology  ·  Exhibit Hall located in Hall B, Level 2
  • «Previous Page
  • 1
  • …
  • 30
  • 31
  • 32
  • 33
  • 34
  • …
  • 53
  • Next Page»

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley